| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1107.85 | $1267.96 | $1179.96 | $1590.33 |
| Short term investments | ||||
| Net receivables | $576.44 | $573.22 | $621.18 | $611.72 |
| Inventory | ||||
| Total current assets | $2116.37 | $1984.07 | $1941.24 | $2324.89 |
| Long term investments | ||||
| Property, plant & equipment | $190.46 | $112.08 | $122.78 | $140.89 |
| Goodwill & intangible assets | $4397.02 | $4485.09 | $4573.05 | |
| Total noncurrent assets | $4699.67 | $4812.02 | $4918.55 | |
| Total investments | ||||
| Total assets | $6725.85 | $6683.73 | $6753.26 | $7243.44 |
| Current liabilities | ||||
| Accounts payable | $15.2 | $400.95 | $429.53 | $399.63 |
| Deferred revenue | $186.3 | $179.51 | $192.78 | |
| Short long term debt | ||||
| Total current liabilities | $876.9 | $841.54 | $902.17 | $894.1 |
| Long term debt | $2238.08 | $2237.24 | $2236.41 | $2711.75 |
| Total noncurrent liabilities | $2425.62 | $2436.36 | $2934.96 | |
| Total debt | $2237.24 | $2236.41 | $2711.75 | |
| Total liabilities | $3542.16 | $3267.16 | $3338.54 | $3829.06 |
| Shareholders' equity | ||||
| Retained earnings | -$3613.22 | -$3488.48 | -$3362.9 | -$3071.83 |
| Other shareholder equity | -$2.99 | -$8.9 | -$7.76 | -$5.01 |
| Total shareholder equity | $3184.69 | $3184.13 | $3182.64 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1590.33 | $1485.08 | $1066.6 | $1293.95 |
| Short term investments | $101.71 | $681.32 | $479.41 | |
| Net receivables | $611.72 | $633.77 | $340.49 | $274.25 |
| Inventory | ||||
| Total current assets | $2324.89 | $2364.64 | $2151.11 | $2080.66 |
| Long term investments | ||||
| Property, plant & equipment | $140.89 | $242.4 | $204.5 | $199.15 |
| Goodwill & intangible assets | $4573.05 | $5123.19 | $2434.51 | $343.71 |
| Total noncurrent assets | $4918.55 | $5469.35 | $2690.24 | $590.57 |
| Total investments | $101.71 | $681.32 | $479.41 | |
| Total assets | $7243.44 | $7833.98 | $4841.35 | $2671.22 |
| Current liabilities | ||||
| Accounts payable | $399.63 | $20.22 | $251.65 | $193.57 |
| Deferred revenue | $192.78 | $321.54 | $156.47 | $134.38 |
| Short long term debt | $23.73 | $25.38 | ||
| Total current liabilities | $894.1 | $1010.28 | $625.53 | $503.22 |
| Long term debt | $2711.75 | $2707.17 | $1795.57 | $98.53 |
| Total noncurrent liabilities | $2934.96 | $3069.57 | $1821.42 | $130.86 |
| Total debt | $2711.75 | $2707.17 | $1819.3 | $123.91 |
| Total liabilities | $3829.06 | $4305.72 | $2446.95 | $634.08 |
| Shareholders' equity | ||||
| Retained earnings | -$3071.83 | -$2249.82 | -$1331.63 | -$797.5 |
| Other shareholder equity | -$5.01 | -$1.69 | -$3.86 | -$3.42 |
| Total shareholder equity | $3182.64 | $3528.27 | $2394.39 | $2037.14 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $446.52 | $449.26 | $460.38 | $609.27 |
| Cost of revenue | $108.88 | $144.39 | $261.58 | |
| Gross Profit | $334.46 | $340.38 | $315.99 | $347.69 |
| Operating activities | ||||
| Research & development | $208.94 | $282.73 | $265.15 | |
| Selling, general & administrative | $260.87 | $408.19 | $341.5 | |
| Total operating expenses | $461.61 | $469.8 | $690.92 | $606.65 |
| Operating income | -$129.42 | -$374.93 | -$258.96 | |
| Income from continuing operations | ||||
| EBIT | -$118.8 | -$297.88 | -$257.72 | |
| Income tax expense | $6.91 | $0.95 | -$12.84 | $9.71 |
| Interest expense | -$5.84 | $5.83 | $6.04 | -$14.69 |
| Net income | ||||
| Net income | -$124.74 | -$125.57 | -$291.07 | -$252.75 |
| Income (for common shares) | -$125.57 | -$291.07 | -$252.75 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2187.32 | $1391.02 | $772.45 | |
| Cost of revenue | $733.72 | $442.5 | $172.35 | |
| Gross Profit | $1453.6 | $948.52 | $600.1 | |
| Operating activities | ||||
| Research & development | $1053.59 | $959.49 | $403.51 | |
| Selling, general & administrative | $1232.8 | $871.25 | $471.39 | |
| Total operating expenses | $2286.39 | $1830.74 | $874.91 | |
| Operating income | -$832.79 | -$882.21 | -$274.81 | |
| Income from continuing operations | ||||
| EBIT | -$828.48 | -$883.79 | -$274.81 | |
| Income tax expense | $28.48 | $37.06 | $2.09 | |
| Interest expense | -$34.95 | $0.21 | $5.41 | |
| Net income | ||||
| Net income | -$822.01 | -$921.06 | -$282.31 | |
| Income (for common shares) | -$822.01 | -$921.06 | -$282.31 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$125.57 | -$291.07 | -$252.75 | |
| Operating activities | ||||
| Depreciation | $101.41 | $101.81 | $232.25 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $115.4 | $265.88 | $180.95 | |
| Total cash flows from operations | $88.38 | -$7.37 | $72.1 | |
| Investing activities | ||||
| Capital expenditures | -$8.77 | -$7.19 | -$11.36 | |
| Investments | ||||
| Total cash flows from investing | -$35.97 | -$9.13 | -$7.19 | -$11.36 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $11.3 | $26 | $10.99 | |
| Net borrowings | -$415 | |||
| Total cash flows from financing | -$357.7 | $11.3 | -$389 | $10.99 |
| Effect of exchange rate | $2 | -$3.26 | -$6.2 | $11.51 |
| Change in cash and equivalents | -$188.3 | $87.3 | -$409.77 | $83.24 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$822.01 | -$921.06 | -$532.61 | -$282.31 |
| Operating activities | ||||
| Depreciation | $563.92 | $211.58 | $64.57 | $42.97 |
| Business acquisitions & disposals | $121.53 | -$1580.08 | -$52.48 | |
| Stock-based compensation | $648.7 | $550.07 | $347.16 | $134.63 |
| Total cash flows from operations | $234.7 | -$59.43 | -$111.45 | $19.91 |
| Investing activities | ||||
| Capital expenditures | -$55.92 | -$57.14 | -$41.94 | -$40.16 |
| Investments | $99.96 | $658.84 | -$215.34 | -$481.81 |
| Total cash flows from investing | $44.04 | $723.23 | -$1837.36 | -$575.19 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$174.01 | -$1436.51 | $66.7 | $1542.88 |
| Net borrowings | $999.62 | $1702.42 | -$0.25 | |
| Total cash flows from financing | -$174.01 | -$226.63 | $1721 | $1701.45 |
| Effect of exchange rate | -$6.15 | $1.93 | $0.46 | $0.67 |
| Change in cash and equivalents | $98.58 | $439.09 | -$227.35 | $1146.85 |
| Market cap | $15.01B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 402.58M |
| Revenue | $1.97B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$794.14M |
| Revenue Q/Q | -17.95% |
| Revenue Y/Y | -3.13% |
| P/E ratio | -18.90 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 7.64 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 2.75 |
| EPS | -$1.97 |
|---|---|
| ROA | -11.59% |
| ROE | N/A |
| Debt/Equity | 1.20 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.41 |
| Quick ratio | N/A |